100 related articles for article (PubMed ID: 10760821)
1. Non-random trisomies of chromosomes 5, 8 and 12 in the prolactinoma sub-type of pituitary adenomas: conventional cytogenetics and interphase FISH study.
Finelli P; Giardino D; Rizzi N; Buiatiotis S; Virduci T; Franzin A; Losa M; Larizza L
Int J Cancer; 2000 May; 86(3):344-50. PubMed ID: 10760821
[TBL] [Abstract][Full Text] [Related]
2. The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas.
Finelli P; Pierantoni GM; Giardino D; Losa M; Rodeschini O; Fedele M; Valtorta E; Mortini P; Croce CM; Larizza L; Fusco A
Cancer Res; 2002 Apr; 62(8):2398-405. PubMed ID: 11956103
[TBL] [Abstract][Full Text] [Related]
3. Aneuploidy, centrosome alteration and securin overexpression as features of pituitary somatotroph and lactotroph adenomas.
Uccella S; Tibiletti MG; Bernasconi B; Finzi G; Oldrini R; Capella C
Anal Quant Cytol Histol; 2005 Oct; 27(5):241-52. PubMed ID: 16447816
[TBL] [Abstract][Full Text] [Related]
4. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
[TBL] [Abstract][Full Text] [Related]
5. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic study of pituitary adenomas.
Bettio D; Rizzi N; Giardino D; Persani L; Pecori-Giraldi F; Losa M; Larizza L
Cancer Genet Cytogenet; 1997 Oct; 98(2):131-6. PubMed ID: 9332478
[TBL] [Abstract][Full Text] [Related]
7. Simple numerical chromosome aberrations in two pituitary adenomas.
Dietrich CU; Pandis N; Bjerre P; Schrøder HD; Heim S
Cancer Genet Cytogenet; 1993 Sep; 69(2):118-21. PubMed ID: 8402547
[TBL] [Abstract][Full Text] [Related]
8. Simple numerical chromosome aberrations characterize pituitary adenomas.
Larsen JB; Schrøder HD; Sørensen AG; Bjerre P; Heim S
Cancer Genet Cytogenet; 1999 Oct; 114(2):144-9. PubMed ID: 10549272
[TBL] [Abstract][Full Text] [Related]
9. The detection of trisomies 8 and 9 in patients with essential thrombocytosis by fluorescence in situ hybridization.
Elis A; Amiel A; Manor Y; Tangi I; Fejgin M; Lishner M
Cancer Genet Cytogenet; 1996 Nov; 92(1):14-7. PubMed ID: 8956864
[TBL] [Abstract][Full Text] [Related]
10. Examination of the relationship between chromosome abnormality in pituitary adenomas and tumor invasiveness by normal karyotype analysis and interphase fluorescence staining.
Gao H; Wang Q; Wu S; Hui G
Med Oncol; 2012 Dec; 29(5):3462-6. PubMed ID: 22772969
[TBL] [Abstract][Full Text] [Related]
11. Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics.
Drieschner N; Rippe V; Laabs A; Dittberner L; Nimzyk R; Junker K; Rommel B; Kiefer Y; Belge G; Bullerdiek J; Sendt W
Cancer Genet; 2011 Jul; 204(7):366-74. PubMed ID: 21872823
[TBL] [Abstract][Full Text] [Related]
12. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
Beyer V; Castagné C; Mühlematter D; Parlier V; Gmür J; Hess U; Kovacsovics T; Meyer-Monard S; Tichelli A; Tobler A; Jacky E; Schanz U; Bargetzi M; Hagemeijer A; de Witte T; van Melle G; Jotterand M
Cancer Genet Cytogenet; 2004 Jul; 152(1):29-41. PubMed ID: 15193439
[TBL] [Abstract][Full Text] [Related]
13. [Cytogenetic analysis in patients with polycythemia vera].
Duan LM; Li JY; Pan JL; Qiu HR; Zhang SJ; Wu YF; Xu W; Xue YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):121-4. PubMed ID: 17490536
[TBL] [Abstract][Full Text] [Related]
14. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
[TBL] [Abstract][Full Text] [Related]
15. Detection and monitoring of trisomy 8 by fluorescence in situ hybridization in acute myeloid leukemia: a multicentric study.
Cuneo A; Bigoni R; Roberti MG; Bardi A; Rigolin GM; Piva N; Mancini M; Nanni M; Alimena G; Mecucci C; Matteucci C; La Starza R; Bernasconi P; Cavigliano P; Genini E; Zaccaria A; Testoni N; Carboni C; Castoldi G
Haematologica; 1998 Jan; 83(1):21-6. PubMed ID: 9542319
[TBL] [Abstract][Full Text] [Related]
16. No increased frequency of trisomies 8 and 9 by fluorescence in situ hybridization in untreated patients with essential thrombocythemia.
Swolin B; Safai-Kutti S; Anghem E; Kutti J
Cancer Genet Cytogenet; 2001 Apr; 126(1):56-9. PubMed ID: 11343780
[TBL] [Abstract][Full Text] [Related]
17. [Trans-septo-sphenoidal operation for pituitary adenoma in 92 patients: results and follow-up endocrine studies].
Gasser RW; Spoendlin H; Finkenstedt G; Pallua AK; Aichner F; Braunsteiner H
Wien Klin Wochenschr; 1993; 105(7):204-7. PubMed ID: 8385381
[TBL] [Abstract][Full Text] [Related]
18. ras mutations in human prolactinomas and pituitary carcinomas.
Cai WY; Alexander JM; Hedley-Whyte ET; Scheithauer BW; Jameson JL; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1994 Jan; 78(1):89-93. PubMed ID: 8288721
[TBL] [Abstract][Full Text] [Related]
19. Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias.
Brizard F; Brizard A; Guilhot F; Tanzer J; Berger R
Leukemia; 1994 Jun; 8(6):1005-11. PubMed ID: 8207973
[TBL] [Abstract][Full Text] [Related]
20. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
